PyInvesting

Market research

QGEN Qiagen NV

NYSE USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
9B
P/E ratio
22.46
Analyst target
46.0693
Dividend yield
0.8%
Beta
0.62

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

QIAGEN N.V is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.2.

QIAGEN N.V's total revenue rose by 38.2% to $571M since the same quarter in the previous year.

Its net income has increased by 373.3% to $213M since the same quarter in the previous year.

Finally, its free cash flow grew by 243.4% to $203M since the same quarter in the previous year.

Based on the above factors, QIAGEN N.V gets an overall score of 5/5.